Dr. Akalin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Department Of Pathology
Worcester, MA 01655Phone+1 508-793-6100Fax+1 508-793-6110
Summary
- Dr. Ali Akalin is a pathologist in Worcester, MA and is affiliated with UMass Memorial Medical Center. He received his medical degree from Ankara University Faculty of Medicine and has been in practice 25 years. He specializes in cytopathology, anatomic pathology, and clinical pathology and is experienced in expertise in general surgical pathology and cytopathology. additional subspecialty expertise in thoracic and head&neck pathology..
Education & Training
UMass Chan Medical SchoolFellowship, Cytopathology, 2006 - 2007
University of Colorado School of Medicine Anschutz Medical CampusSurgical Pathology, 2005 - 2006- University of ColoradoResidency, Pathology-Anatomic and Clinical, 2001 - 2005
Virginia Commonwealth UniversityPh.D., Experimental Pathology, 1997 - 2000
Ankara University FOMClass of 1992
Certifications & Licensure
MA State Medical License 2007 - 2026
CT State Medical License 2008 - 2021
CO State Medical License 2004 - 2009- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 48 citationsKeratin 17 identifies the most lethal molecular subtype of pancreatic cancerLucia Roa-Peña, Cindy V. Leiton, Sruthi Babu, Chun-Hao Pan, Elizabeth A. Vanner
Scientific Reports. 2019-08-02 - 7 citationsKeratin 17 Expression Predicts Poor Clinical Outcome in Patients With Advanced Esophageal Squamous Cell Carcinoma.Kester Haye, Sruthi Babu, Lyanne Oblein, Rajarsi Gupta, Ali Akalin
Applied Immunohistochemistry & Molecular Morphology. 2021-02-01 - 31 citationsKeratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.Daniel C. Mockler, Luisa F. Escobar-Hoyos, Ali Akalin, Jamie L. Romeiser, A. Laurie Shroyer
American Journal of Clinical Pathology. 2017-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
